Epigenomics AG Share Price Deutsche Boerse AG
Equities
DE000A1K0516
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
04-30 | Epigenomics AG Announces Jens Ravens Leaves as Executive Board Member | CI |
03-14 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.42M 1.55M 121M |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 2.48M 2.69M 211M | Net cash position 2025 * | 1.39M 1.51M 118M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.81
x | P/E ratio 2025 * |
-2.83
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.77% |
Managers | Title | Age | Since |
---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
Annett Dietrich
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Helge Lubenow
CHM | Chairman | 56 | 24/05/16 |
Jochen Hummel
BRD | Director/Board Member | 54 | 02-04 |
Alexander Link
BRD | Director/Board Member | 53 | 31/05/20 |
1st Jan change | Capi. | |
---|---|---|
+3.25% | 3.43B | |
-0.37% | 2.27B | |
-19.19% | 2.03B | |
-22.57% | 1.63B | |
+32.82% | 1.16B | |
+14.12% | 714M | |
-8.30% | 703M | |
-31.22% | 500M | |
-4.97% | 279M |